Internal Medicine, Cardiovascular Disease · Alabaster, AL
NPI
1508843061
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1022 1st St N, Suite 500
Alabaster, AL, 35007
Phone (205) 663-5775
Groups this clinician bills Medicare through
Medicare paid, 2024
$178K
5,835 services
Medicare patients, 2024
557
Average age 77
Drug cost, 2024
$1.6M
10,972 prescriptions
Company payments, 2025
$45.12
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John D McBrayer was code 99214 (office e&m - established), 866 times for 362 patients. In total John D McBrayer billed 5,835 services in 62 codes, and Medicare paid $178K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 866 | 362 | $78.71 | $68K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 563 | 307 | $11.95 | $6,730 |
| 93000 Electrocardiogram | Office | 496 | 318 | $8.75 | $4,340 |
| 99454 E&M - Miscellaneous | Office | 453 | 57 | $31.71 | $14K |
| 99457 E&M - Miscellaneous | Office | 397 | 56 | $34.85 | $14K |
| 85025 Blood Count | Office | 343 | 213 | $7.60 | $2,608 |
| 99458 E&M - Miscellaneous | Office | 332 | 50 | $28.15 | $9,345 |
| 36415 Venipuncture Blood Collection | Office | 301 | 197 | $8.65 | $2,604 |
| 80053 Clinical Chemistry | Office | 282 | 196 | $10.35 | $2,919 |
| 84443 Clinical Chemistry | Office | 262 | 186 | $16.46 | $4,313 |
| 80061 Clinical Chemistry | Office | 258 | 186 | $13.00 | $3,354 |
| 82550 Clinical Chemistry | Office | 240 | 174 | $6.35 | $1,525 |
| 93294 External Electrocardiographic Monitoring | Office | 126 | 37 | $19.98 | $2,517 |
| 93306 Echocardiography (TTE/TEE) | Office | 105 | 105 | $124.05 | $13K |
| 80048 Clinical Chemistry | Office | 83 | 55 | $8.25 | $685 |
By year: 2022 $206K for 6,595 services; 2023 $186K for 6,688 services; 2024 $178K for 5,835 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 343 | 213 | $7.60 | $2,608 |
| 36415 Venipuncture Blood Collection | 301 | 197 | $8.65 | $2,604 |
| 80053 Clinical Chemistry | 282 | 196 | $10.35 | $2,919 |
| 84443 Clinical Chemistry | 262 | 186 | $16.46 | $4,313 |
| 80061 Clinical Chemistry | 258 | 186 | $13.00 | $3,354 |
| 82550 Clinical Chemistry | 240 | 174 | $6.35 | $1,525 |
| 80048 Clinical Chemistry | 83 | 55 | $8.25 | $685 |
| 83735 Clinical Chemistry | 68 | 59 | $6.57 | $447 |
Medicare prescription drug claims, 2024
In 2024, the drug John D McBrayer prescribed most often to Medicare patients was Eliquis (Apixaban), with 745 prescriptions and refills. In total John D McBrayer wrote 10,972 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 745 | 1,085 | 138 | $609K |
| Metoprolol Succinate Generic | 735 | 1,963 | 224 | $13K |
| Carvedilol Generic | 513 | 1,364 | 153 | $4,741 |
| Atorvastatin Calcium Generic | 504 | 1,459 | 158 | $7,646 |
| Furosemide Generic | 484 | 1,241 | 168 | $2,393 |
| Amlodipine Besylate Generic | 386 | 1,037 | 119 | $3,078 |
| Clopidogrel Clopidogrel Bisulfate | 367 | 1,033 | 109 | $5,333 |
| Losartan Potassium Generic | 360 | 951 | 113 | $4,556 |
| Repatha Sureclick Evolocumab | 330 | 452 | 58 | $253K |
| Potassium Chloride Generic | 307 | 757 | 100 | $7,305 |
| Rosuvastatin Calcium Generic | 302 | 836 | 103 | $6,572 |
| Pravastatin Sodium Generic | 277 | 770 | 87 | $6,885 |
| Lisinopril Generic | 273 | 771 | 93 | $2,384 |
| Entresto Sacubitril/Valsartan | 272 | 376 | 48 | $229K |
| Hydrochlorothiazide Generic | 234 | 652 | 79 | $1,002 |
Brand drugs: 1,998 claims; generic drugs: 8,974 claims; opioid claims: 69.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John D McBrayer $45.12 ($45.12 in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $31.34.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.